The Effect of a Therapy Dog Activity on Employees' Stress, Mood, and Job Satisfaction and Commitment

March 26, 2019 updated by: Virginia Commonwealth University
The goal of the current study is to determine if participating in a therapy dog activity is associated with changes in perceived stress, mood, and job satisfaction and commitment. A secondary goal is to explore a potential dose effect of multiple treatments as well as control for novelty effect.

Study Overview

Detailed Description

This study will be conducted at Aetna Headquarters in Hartford, Connecticut. A pre-post repeated measures design will be used to compare study participant outcomes between a treatment (therapy dog activity) and comparison (low impact physical activity) condition. Outcome variables of interest are perceived stress measured by a stress visual analog scale (SVAS), mood measured by the Positive and Negative Affect Scale (PANAS), and job satisfaction and commitment measured by an investigator-developed Job Satisfaction Survey (consisting of a combination of existing validated scales). Pet ownership, attitudes toward dogs measured by the Dog Attitude Scale, and trait stress, measured by the Perceived Stress Scale, will be assessed as moderating variables.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Connecticut
      • Hartford, Connecticut, United States, 06156
        • Aetna Headquarters
    • Virginia
      • Richmond, Virginia, United States, 23298
        • Virginia Commonwealth University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Current Aetna employees

Exclusion Criteria:

  • Individuals not employed by Aetna. Note:employees are self-selecting to participate, therefore dog fears or allergies are not listed as exclusion criteria.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Therapy dog activity
Interact with visiting therapy dogs for 15 minutes on two Fridays
Visiting therapy dogs and their owners, evaluated and registered as therapy dog teams with Pet Partners will be spread around a large room on the Aetna campus. Employees will arrive at scheduled times to visit with the dogs for 15 minutes, talking to the dogs and owners and petting the dogs
Active Comparator: Low impact physical activity
Participate in 15-minute low impact physical activity on two Fridays
The low impact exercise will consist of stretching exercises conducted by a member of Aetna's wellness team in the same room for 15 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Single Item Stress Measure
Time Frame: Baseline to week 3
Changes in self reported stress on visual analog scale (VAS) immediately before and after each activity. Scale ranges from "none" to "most severe imaginable" on 15 cm scale.
Baseline to week 3
20-item Positive and Negative Affect Schedule
Time Frame: Baseline to week 3
Self reported mood immediately before and after each activity. Each item is scored 1-5 (1 = strongly disagree; 5 = strongly agree). 10 items comprise the positive affect scale with scores ranging from 10 - 50, with higher scores indicating higher positive affect. 10 items comprise the negative affect scale with total scores ranging from 10 - 50, with lower scores indicating lower negative affect.
Baseline to week 3

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Single Item Stress Measure
Time Frame: Baseline to week 5
Changes in self reported stress on visual analog scale (VAS) after two intervention activities. Scale ranges from "none" to "most severe imaginable" on 15 cm scale.
Baseline to week 5
20-item Positive and Negative Affect Schedule
Time Frame: Baseline to week 5
Self reported mood two intervention activities. Each item is scored 1-5 (1 = strongly disagree; 5 = strongly agree). 10 items comprise the positive affect scale with scores ranging from 10 - 50, with higher scores indicating higher positive affect. 10 items comprise the negative affect scale with total scores ranging from 10 - 50, with lower scores indicating lower negative affect.
Baseline to week 5
9-item Job Satisfaction and Commitment Scale
Time Frame: Baseline to week 5
Self reported job satisfaction ( 3 items) and commitment (6 items) at baseline, after the first and last activity. Each item is scored 1-5 (1 = strongly disagree, 5 = strongly agree). Total scores range from 9-45 with higher scores indicating greater job satisfaction and commitment
Baseline to week 5

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Sandra Barker, PhD, Virginia Commonwealth University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

March 15, 2019

Primary Completion (Anticipated)

May 10, 2019

Study Completion (Anticipated)

July 12, 2019

Study Registration Dates

First Submitted

November 21, 2018

First Submitted That Met QC Criteria

February 19, 2019

First Posted (Actual)

February 21, 2019

Study Record Updates

Last Update Posted (Actual)

March 28, 2019

Last Update Submitted That Met QC Criteria

March 26, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • HM20014106

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

Clinical Trials on Therapy dog activity

3
Subscribe